Literature DB >> 17565544

Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women.

Alpana Sharma1, Abhigyan Satyam, Jai Bhagwan Sharma.   

Abstract

PROBLEM: Despite progress in immunobiology, pre-eclampsia (PE) remains one of the most common reasons for women to die during pregnancy. The widespread pathophysiological mechanisms are endothelial dysfunction, oxidative stress and inflammation. The aim of this study was to assess the alteration in the levels of leptin, interleukin (IL)-10 and inflammatory cytokines [tumour necrosis factor (TNF)-alpha, IL-6 & IL-8] in pre-eclamptic (severe and mild), healthy pregnant and non-pregnant women and correlate these parameters with disease severity. METHOD OF STUDY: The levels of leptin, IL-10 and inflammatory cytokines were measured by high sensitivity enzyme-linked immunoabsorbant assay. The study subjects were 54 pre-eclamptic women (ten severe and 45 milder), compared by age matched 50 healthy pregnant and 27 non-pregnant women. Kruskal-Wallis non-parametric analyses of variance followed by Mann-Whitney U-test were used for statistical analysis.
RESULTS: The levels of leptin, TNF-alpha, IL-6 &amp; IL-8 in pre-eclamptic subjects were increased significantly when compared with the healthy control pregnant and non-pregnant (P < 0.000). The concentration of IL-10 has shown different pattern as its level decreased significantly (0.001) in pre-eclamptic women (overall) in comparison with control subjects (pregnant &amp; non-pregnant). A combination of 80% or higher sensitivity and specificity was seen in the parameters analysed, except IL-8 and IL-10.
CONCLUSION: Our findings suggest a relationship among TNF-alpha, IL-6, IL-8, IL-10 and leptin and indicate that altered levels of above markers in PE might be used as markers of pro-inflammation/anti-inflammation and endothelial dysfunction in pre-eclamptic pregnancies. These results also advocate the abnormal leptin and cytokine responses in mother, which might be involved in the pathogenesis of PE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565544     DOI: 10.1111/j.1600-0897.2007.00486.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  72 in total

1.  IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?

Authors:  Babbette Lamarca; Justin Brewer; Kedra Wallace
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-07-01

2.  The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2010-04

3.  Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system.

Authors:  Kedra Wallace; Sarah Novotny; Judith Heath; Janae Moseley; James N Martin; Michelle Y Owens; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-05-30       Impact factor: 3.619

4.  Pathways linking childhood abuse history and current socioeconomic status to inflammation during pregnancy.

Authors:  M Sima Finy; Lisa M Christian
Journal:  Brain Behav Immun       Date:  2018-09-11       Impact factor: 7.217

5.  Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.

Authors:  Kelly K Ferguson; John D Meeker; Thomas F McElrath; Bhramar Mukherjee; David E Cantonwine
Journal:  Am J Obstet Gynecol       Date:  2016-12-30       Impact factor: 8.661

Review 6.  Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Michael J Ryan; Jeffrey S Gilbert; Sydney R Murphy; Joey P Granger
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

7.  Correlation of Plasma Neutrophil Elastase Activity and Endogenous Protease Inhibitor Levels with the Severity of Pre-eclampsia.

Authors:  Mamatha Kunder; Av Moideen Kutty; V Lakshmaiah; S R Sheela
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  First-Trimester Inflammatory Markers for Risk Evaluation of Pregnancy Hypertension.

Authors:  Karuna Sharma; Ritu Singh; Manisha Kumar; Usha Gupta; Vishwajeet Rohil; Jayashree Bhattacharjee
Journal:  J Obstet Gynaecol India       Date:  2017-04-19

9.  Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Authors:  Shali Mazaki-Tovi; Roberto Romero; Sun Kwon Kim; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Chia-Ling Nhan-Chang; Nandor Gabor Than; Ricardo Gomez; Jyh Kae Nien; Samuel S Edwin; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

10.  Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls.

Authors:  Brandie D Taylor; Gong Tang; Roberta B Ness; Jørn Olsen; David M Hougaard; Kristin Skogstrand; James M Roberts; Catherine L Haggerty
Journal:  Pregnancy Hypertens       Date:  2015-11-10       Impact factor: 2.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.